Heart Disease Trial, Recruiting NCT07137936 Sponsor: Beijing Anzhen Hospital Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07137936
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 80 years old
  • People who have had a heart attack and have since had a specific heart scan (called a cardiac MRI) at Anzhen Hospital at least one month after the heart attack, during a stable period of recovery

Who may not be able to join:

  • People who already had a defibrillator device (ICD or CRT-D) implanted in their heart before their heart attack
  • People who had already been diagnosed with a heart rhythm disorder — such as long QT syndrome or Brugada syndrome — before their heart attack
  • People who have a serious illness at the same time, such as advanced cancer, that is expected to result in a life expectancy of less than one year
  • People who had already been diagnosed with a non-heart-attack-related heart muscle disease — such as dilated, hypertrophic, or restrictive cardiomyopathy — before their heart attack
  • People who have significant heart valve disease, or who have previously had a mechanical heart valve replacement
  • People who are unwilling to attend follow-up appointments as part of the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Anzhen Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
31 December 2036

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Sudden cardiac death (SCD)-equivalent events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov